EP3411484
Inndæling einþátta eða sjálfsamfallandi eitlatengdrar veiru 9 inn í heila- og mænuvökvann
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.1.2017EP published:
4.10.2023EP application number:
17747935.9
EP translation filed:
31.10.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
24.1.2037Expiry date:
24.1.2027Next due date:
31.1.2027
Title in English:
INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS 9 INTO THE CEREBROSPINAL FLUIDLanguage of the patent:
English
Timeline
Today
25.1.2017EP application
4.10.2023EP Publication
31.10.2023Translation submitted
15.12.2023Registration published
24.1.2027Expires
Owner
Name:
Emory UniversityAddress:
1599 Clifton Road NE 4th Floor, Atlanta, GA 30322, US
Name:
REGENXBIO Inc.Address:
9804 Medical Center Drive, Rockville, MD 20850, US
Inventor
Name:
DONSANTE, AnthonyAddress:
Decatur, GA 30033, US
Name:
KOZARSKY, KarenAddress:
Bala Cynwyd, PA 19004, US
Name:
BOULIS, Nicholas MatthewAddress:
Atlanta, GA 30308, US
Name:
RILEY, Jonathan PatrickAddress:
Williamsville NY 14221, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201662292157 PDate:
5.2.2016Country:
US
Classification
Categories:
C12N 15/63, C12N 15/861, A61K 48/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.1.2024
Expires: 24.1.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.1.2025
Expires: 24.1.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.1.2026
Expires: 24.1.2027
Payer: Árnason Faktor ehf.